Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome by EFSA Panel on Plant Protection Products and their Residues (PPR), Antonio F Hernandez‐Jerez, Paulien Adriaanse, Annette Aldrich, Philippe Berny, Tamara Coja, Sabine Duquesne, Andreas Focks, Maurice Millet, Olavi Pelkonen, Silvia Pieper, Aaldrik Tiktak, Christopher J Topping, Anneli Widenfalk, Martin Wilks, Gerrit Wolterink, Karine Angeli, Camilla Recordati, Majorie Van Duursen, Elisa Aiassa, Anna Lanzoni, Alfonso Lostia, Laura Martino, Irene Pilar Munoz Guajardo, Martina Panzarea, Andrea Terron, Marina Marinovich

Get full text